Inhibition of atherosclerosis by angiotensin II type 1 receptor antagonists.

about

Valsartan ameliorates ageing-induced aorta degeneration via angiotensin II type 1 receptor-mediated ERK activity Effects of angiotensin receptor blockers on neointimal characteristics in angina patients requiring stent implantation: optical coherence tomography analysis.

P2860

Q35867839-87E5B8E6-95FC-419B-A3FC-3B9568AED252 Q47160670-D1C4E933-B491-4ABA-AAB0-D1FE59C4DFEC

P2860

Inhibition of atherosclerosis by angiotensin II type 1 receptor antagonists.

Item

http://www.wikidata.org/entity/Q44065629

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Inhibition of atherosclerosis by angiotensin II type 1 receptor antagonists.

@en

Inhibition of atherosclerosis by angiotensin II type 1 receptor antagonists.

@nl

type

Item

label

Inhibition of atherosclerosis by angiotensin II type 1 receptor antagonists.

@en

Inhibition of atherosclerosis by angiotensin II type 1 receptor antagonists.

@nl

prefLabel

Inhibition of atherosclerosis by angiotensin II type 1 receptor antagonists.

@en

Inhibition of atherosclerosis by angiotensin II type 1 receptor antagonists.

@nl

P1476

Inhibition of atherosclerosis by angiotensin II type 1 receptor antagonists.

@en

P2093

Stefan Peters

http://www.w3.org/2001/XMLSchema#string

P2860

Sex difference in vascular injury and the vasoprotective effect of valsartan are related to differential AT2 receptor expression

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Telmisartan, ramipril, or both in patients at high risk for vascular events.

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

Effect of angiotensin receptor blockade on endothelial function: focus on olmesartan medoxomil

Neointimal hyperplasia inhibition effect of angiotensin II type 1 receptor blockers in patients after coronary stent implantation: a meta-analysis.

Effects of valsartan and 17 beta-estradiol on the oxidation of low-density lipoprotein in vitro.

Four-year clinical outcomes of the OLIVUS-Ex (impact of Olmesartan on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) extension trial.

Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial.

AT1-receptor antagonism improves endothelial function in coronary artery disease by a bradykinin/B2-receptor-dependent mechanism.

P2888

s40256-013-0017-4

P304

221-224

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40256-013-0017-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23609531

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

Inhibition of atherosclerosis by angiotensin II type 1 receptor antagonists.

about

P2860

P2860

Inhibition of atherosclerosis by angiotensin II type 1 receptor antagonists.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921